Furthermore, in a syngeneic BALB/c mouse model, anti-PD-1 treatment significantly reduced tumor growth and extended survival in mice bearing 4T1-P (anti–PD-1–responsive) tumors, but not in those bearing Tyro3-OE (Tyro3-overexpressing) tumors. The gene discussed is PDCD1; the disease is neoplasm.